Pharmaceutical

A rational design approach to RNA-targeting to target large-scale screening

At ELRIG 2024, Dr. Maria Duca described how her lab’s rational design approach bypasses lengthy screening protocols.

Oct 4, 2024 - 04:00
A rational design approach to RNA-targeting to target large-scale screening
At ELRIG 2024, Dr. Maria Duca described how her lab’s rational design approach bypasses lengthy screening protocols.
Read the original article

Tags:

Previous Article

FDA authorizes the first novel schizophrenia therapy in decades

Next Article

Resolution scores $83m to develop macrophage cell therapies

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Republicans consider a new attack on Biden ‘march-in’ plan for lower drug prices

STAT+: Republicans consider a new attack on Biden ‘marc...

Mar 6, 2024

STAT+: Sophisticated phishing and deepfakes: How generative AI brings new threats for hospitals

STAT+: Sophisticated phishing and deepfakes: How genera...

Jan 30, 2024

STAT+: In surprise move, FDA calls for advisory committee on Lilly’s Alzheimer’s drug

STAT+: In surprise move, FDA calls for advisory committ...

Mar 8, 2024